Investigators from the University of Chicago Medicine will play a central role in a five-year, $14.8 million effort by the National Institutes of Health, contingent upon available funding, to improve the understanding of inherited diseases.
Sunbathers may want to avoid midnight snacks before catching some rays.
The American Chiropractic Association (ACA) today released a list of five tests and procedures commonly ordered but not always necessary in chiropractic care.
Up to $14.8 million over five years, contingent on available funds, was announced today by The National Institutes of Health (NIH) Common Fund’s Gabriella Miller Kids First Pediatric Research Program (Kids First). Researchers in Canada and the United States are using these funds to join together and build a centralized, cloud-based database and discovery portal of genetic and clinical data called the Kids First Data Resource Center (DRC).
Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.
An intracellular metabolite of glutamine regulates cellular differentiation programs by changing the DNA-binding patterns of a transcription factor and by altering genome interactions. Genome context near the binding sites affects whether the binding turns on or turns off gene programs.
Staring at the sun – even during a sky-darkening eclipse – requires extra eye safety precautions. Here's how to skygaze safely during the eclipse and a rundown of what can happen if you don't.
Jim Cawley, CLA ’91, LAW ’94, a former Pennsylvania lieutenant governor, most recently served as president and CEO of United Way of Greater Philadelphia and Southern New Jersey.
The National Psoriasis Foundation has announced the winners of its Medical Professional Research Awards. Joel M. Gelfand, MD MSCE, a professor of Dermatology and Epidemiology, received the 2017 Outstanding Scientific Achievement Award. The award for Outstanding New Investigator went to Junko Takeshita, MD, PhD, MSCE, an assistant professor of Dermatology and Epidemiology.
Some children born with birth defects may be at increased risk for specific types of cancer, according to a new review from the Brown School and the School of Medicine at Washington University in St. Louis.
New information about how and where the innate immune system fights off viral infections that enter through the skin could lead to better treatments for viruses like Zika, dengue and measles, according to Penn State College of Medicine researchers.
A new clinical trial led by investigators at NewYork-Presbyterian, Columbia University Medical Center (CUMC) and Weill Cornell Medicine aims to identify and treat what may be a common underlying cause of recurrent strokes.
A new study finds that more than half of women with early stage breast cancer considered an aggressive type of surgery to remove both breasts. The way women generally approach big decisions, combined with their values, impacts what breast cancer treatment they consider, the study also found.
The Center for Data Driven Discovery in Biomedicine at Children’s Hospital of Philadelphia (CHOP) will lead a new, collaborative effort funded by the National Institutes of Health Common Fund to discover the causes of pediatric cancer and structural birth defects through the use of big data. The Center will be known as the “Kids First Pediatric Data Resource Center” (DRC).
Botulinum toxin is of statistically significant benefit for a surprisingly common cause of crippling, often chronic, back pain, sciatica and especially buttock pain.
Recognized in the Top 3% of All United States and Canadian Hospitals for Coronary Artery Bypass Grafting and Aortic Valve Replacement
The University of New Mexico Comprehensive Cancer Center began helping New Mexicans with blood disorders a little more than one year ago. It is the state’s only bone marrow transplant program. The program offers treatment choices for people with lymphoma and myeloma and will expand to help people with other blood disorders.
The aim of targeted gene-based cancer therapies could often be skewed from the start. A widespread concept about how cells produce proteins proved incorrect 62% of the time in a new study in ovarian cancer cells of the relationship between RNA and protein levels.
Indiana University School of Medicine researchers have developed a more precise way of diagnosing suicide risk, by developing blood tests that work in everybody
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right